| David W Munter, MD | |
|
516 Innovation Dr Ste 102, Chesapeake, VA 23320-3866 | |
| (513) 834-7063 | |
| Not Available |
| Full Name | David W Munter |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 42 Years |
| Location | 516 Innovation Dr Ste 102, Chesapeake, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073545232 | NPI | - | NPPES |
| 6056750 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RA0401X | Internal Medicine - Addiction Medicine | 0101035687 (Virginia) | Secondary |
| 207P00000X | Emergency Medicine | 0101035687 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Home Health Of Virginia | Virginia beach, VA | Home health agency |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hyperbaric Physician Services, Llc | 6507806478 | 6 |
News Archive
"The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?" Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post "Impact" blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs "deals with treatment, the target on 'essential medicines and basic technologies for treatment.'"
A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body.
Mild cognitive impairment, or MCI, may be one of Alzheimer's earliest signs. The subtle changes of MCI include problems with memory, language, thinking and judgment and a subjective sense that mental function is getting worse.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.
Healthcare staff need to challenge their own assumptions about what is 'normal' if they are to provide non-discriminatory care to autistic people, according to authors writing in the journal Learning Disability Practice.
› Verified 6 days ago
| Entity Name | Hyperbaric Physician Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689642027 PECOS PAC ID: 6507806478 Enrollment ID: O20050510000798 |
News Archive
"The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?" Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post "Impact" blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs "deals with treatment, the target on 'essential medicines and basic technologies for treatment.'"
A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body.
Mild cognitive impairment, or MCI, may be one of Alzheimer's earliest signs. The subtle changes of MCI include problems with memory, language, thinking and judgment and a subjective sense that mental function is getting worse.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.
Healthcare staff need to challenge their own assumptions about what is 'normal' if they are to provide non-discriminatory care to autistic people, according to authors writing in the journal Learning Disability Practice.
› Verified 6 days ago
| Entity Name | Brightview Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649786260 PECOS PAC ID: 9032426044 Enrollment ID: O20220401000078 |
News Archive
"The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?" Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post "Impact" blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs "deals with treatment, the target on 'essential medicines and basic technologies for treatment.'"
A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body.
Mild cognitive impairment, or MCI, may be one of Alzheimer's earliest signs. The subtle changes of MCI include problems with memory, language, thinking and judgment and a subjective sense that mental function is getting worse.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.
Healthcare staff need to challenge their own assumptions about what is 'normal' if they are to provide non-discriminatory care to autistic people, according to authors writing in the journal Learning Disability Practice.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David W Munter, MD 615 Elsinore Pl Ste 200, Cincinnati, OH 45202-1457 Ph: (513) 834-7063 | David W Munter, MD 516 Innovation Dr Ste 102, Chesapeake, VA 23320-3866 Ph: (513) 834-7063 |
News Archive
"The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?" Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post "Impact" blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs "deals with treatment, the target on 'essential medicines and basic technologies for treatment.'"
A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body.
Mild cognitive impairment, or MCI, may be one of Alzheimer's earliest signs. The subtle changes of MCI include problems with memory, language, thinking and judgment and a subjective sense that mental function is getting worse.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.
Healthcare staff need to challenge their own assumptions about what is 'normal' if they are to provide non-discriminatory care to autistic people, according to authors writing in the journal Learning Disability Practice.
› Verified 6 days ago
Michele A Ansorge, PA Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4053 Taylor Rd, Suite N, Chesapeake, VA 23321 Phone: 757-484-5900 Fax: 757-483-6671 | |
Laura Lee Woodard, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 736 Battlefield Blvd N, Chesapeake General Hospital, Chesapeake, VA 23320 Phone: 757-312-6200 | |
Jennifer Himmel Salch, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 736 Battlefield Blvd N, Chesapeake, VA 23320 Phone: 757-490-9388 Fax: 757-490-9401 | |
Dr. Mark Carroll Hughes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 736 Battlefield Blvd N, Chesapeake, VA 23320 Phone: 757-312-6200 Fax: 757-312-6181 | |
Timothy S Nelson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 736 Battlefield Blvd N, Emergency Department, Chesapeake, VA 23320 Phone: 757-312-6200 Fax: 757-312-6181 | |
Dr. Jonathan Aaron Romash, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 736 Battlefield Blvd N, Emergency Department, Chesapeake, VA 23320 Phone: 757-312-6200 Fax: 757-312-6181 | |
Dr. Julie Ann Brown, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 736 Battlefield Blvd N, Chesapeake General Hospital, Chesapeake, VA 23320 Phone: 757-312-6200 |